AVIR

Atea Pharmaceuticals, Inc.$4.74+0.12 (+2.60%)

Prev Close$4.62·MCap$378.5M·P/E—·Vol396.1K·Yield—

▲

Buys (12M)

$50.9K

▼

Sells (12M)

$746.7K

◆

Net Activity

Net Seller

$695.8K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Atea Pharmaceuticals, Inc. (AVIR) has been dominated by selling, with 2 insider purchases totaling $50.9K and 6 insider sales totaling $746.7K. The most recent insider transaction was by Murphy Polly A. (director), who purchased $25.4K worth of shares on May 21, 2026. Atea Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $378.5M.

AVIR Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 21, 2026	Murphy Polly A.	director	Buy	6,100	$4.17	$25.4K	92,145
May 20, 2026	Murphy Polly A.	director	Buy	6,100	$4.17	$25.4K	92,145
Jan 31, 2026	Corcoran Andrea	See Remarks	Sell	16,104	$4.24	$68.3K	0
Jan 31, 2026	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,132	$4.24	$51.4K	0
Jan 31, 2026	Hammond Janet MJ	Chief Development Officer	Sell	14,136	$4.24	$59.9K	0
Jan 31, 2026	Horga Maria Arantxa	Chief Medical Officer	Sell	16,073	$4.24	$68.1K	0
Jan 31, 2026	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	106,093	$4.24	$449.8K	0
Jan 31, 2026	Vavricka John	Chief Commercial Officer	Sell	11,570	$4.24	$49.1K	0
Jan 31, 2025	Corcoran Andrea	See Remarks	Sell	16,102	$3.06	$49.3K	0
Jan 31, 2025	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,062	$3.06	$36.9K	0
Jan 31, 2025	Hammond Janet MJ	Chief Development Officer	Sell	14,134	$3.06	$43.3K	0
Jan 31, 2025	Horga Maria Arantxa	Chief Medical Officer	Sell	16,071	$3.06	$49.2K	0
Jan 31, 2025	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	88,601	$3.06	$271.1K	0
Jan 31, 2025	Vavricka John	Chief Commercial Officer	Sell	11,517	$3.06	$35.2K	0
Jan 15, 2025	BERGER FRANKLIN M	Director	Sell	25,000	$3.26	$81.5K	0
Dec 10, 2024	BERGER FRANKLIN M	Director	Sell	359,606	$2.85	$1.02M	0
Sep 17, 2024	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	57,969	$4.04	$234.2K	0
Jun 20, 2024	Polsky Bruce	Director	Sell	17,544	$3.49	$61.1K	0
Jun 5, 2024	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	1,006	$4.00	$4.0K	0
Jan 31, 2024	Corcoran Andrea	See Remarks	Sell	15,843	$3.84	$60.9K	0
Jan 31, 2024	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,477	$3.84	$47.9K	0
Jan 31, 2024	Hammond Janet MJ	Chief Development Officer	Sell	14,029	$3.84	$53.9K	0
Jan 31, 2024	Horga Maria Arantxa	Chief Medical Officer	Sell	15,870	$3.84	$61.0K	0
Jan 31, 2024	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	56,910	$3.85	$218.8K	0
Jan 31, 2024	Vavricka John	Chief Commercial Officer	Sell	11,819	$3.84	$45.4K	0
Nov 11, 2022	BERGER FRANKLIN M	Director	Sell	41,666	$5.15	$214.7K	0
Dec 20, 2021	Murphy Polly A.	Director	Buy	12,000	$8.57	$102.8K	0

AVIR Insider Buying Activity

The following table shows recent insider purchases of Atea Pharmaceuticals, Inc. (AVIR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 21, 2026	Murphy Polly A.	director	Buy	6,100	$4.17	$25.4K	92,145
May 20, 2026	Murphy Polly A.	director	Buy	6,100	$4.17	$25.4K	92,145
Dec 20, 2021	Murphy Polly A.	Director	Buy	12,000	$8.57	$102.8K	0

AVIR Insider Selling Activity

The following table shows recent insider sales of Atea Pharmaceuticals, Inc. (AVIR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Jan 31, 2026	Corcoran Andrea	See Remarks	Sell	16,104	$4.24	$68.3K
Jan 31, 2026	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,132	$4.24	$51.4K
Jan 31, 2026	Hammond Janet MJ	Chief Development Officer	Sell	14,136	$4.24	$59.9K
Jan 31, 2026	Horga Maria Arantxa	Chief Medical Officer	Sell	16,073	$4.24	$68.1K
Jan 31, 2026	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	106,093	$4.24	$449.8K
Jan 31, 2026	Vavricka John	Chief Commercial Officer	Sell	11,570	$4.24	$49.1K
Jan 31, 2025	Corcoran Andrea	See Remarks	Sell	16,102	$3.06	$49.3K
Jan 31, 2025	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,062	$3.06	$36.9K
Jan 31, 2025	Hammond Janet MJ	Chief Development Officer	Sell	14,134	$3.06	$43.3K
Jan 31, 2025	Horga Maria Arantxa	Chief Medical Officer	Sell	16,071	$3.06	$49.2K
Jan 31, 2025	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	88,601	$3.06	$271.1K
Jan 31, 2025	Vavricka John	Chief Commercial Officer	Sell	11,517	$3.06	$35.2K
Jan 15, 2025	BERGER FRANKLIN M	Director	Sell	25,000	$3.26	$81.5K
Dec 10, 2024	BERGER FRANKLIN M	Director	Sell	359,606	$2.85	$1.02M
Sep 17, 2024	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	57,969	$4.04	$234.2K
Jun 20, 2024	Polsky Bruce	Director	Sell	17,544	$3.49	$61.1K
Jun 5, 2024	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	1,006	$4.00	$4.0K
Jan 31, 2024	Corcoran Andrea	See Remarks	Sell	15,843	$3.84	$60.9K
Jan 31, 2024	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,477	$3.84	$47.9K
Jan 31, 2024	Hammond Janet MJ	Chief Development Officer	Sell	14,029	$3.84	$53.9K
Jan 31, 2024	Horga Maria Arantxa	Chief Medical Officer	Sell	15,870	$3.84	$61.0K
Jan 31, 2024	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	56,910	$3.85	$218.8K
Jan 31, 2024	Vavricka John	Chief Commercial Officer	Sell	11,819	$3.84	$45.4K
Nov 11, 2022	BERGER FRANKLIN M	Director	Sell	41,666	$5.15	$214.7K